Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.

about

Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q38786377

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Bleomycin pulmonary toxicity d ...... atients with Hodgkin lymphoma.

@en

type

Item

label

Bleomycin pulmonary toxicity d ...... atients with Hodgkin lymphoma.

@en

prefLabel

Bleomycin pulmonary toxicity d ...... atients with Hodgkin lymphoma.

@en

P1476

Bleomycin pulmonary toxicity d ...... atients with Hodgkin lymphoma.

@en

P2093

Haowei Linda Sun

http://www.w3.org/2001/XMLSchema#string

John Kuruvilla

http://www.w3.org/2001/XMLSchema#string

Michael Crump

http://www.w3.org/2001/XMLSchema#string

Theodore K Marras

http://www.w3.org/2001/XMLSchema#string

Vishal Kukreti

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?

Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Bleomycin-induced pneumonitis.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

P304

2607-2614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1307980

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eshetu G. Atenafu

Richard W. Tsang

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28504035

http://www.w3.org/2001/XMLSchema#string